Skip to main content
Paul Goepfert, MD, Infectious Disease, Birmingham, AL

PaulAGoepfertMD

Infectious Disease Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Dr. Goepfert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goepfert's full profile

Already have an account?

  • Office

    619 19th St S
    Birmingham, AL 35233
    Phone+1 205-934-6600

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Infectious Disease, 1994 - 1997
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1991

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1992 - 2024
  • TX State Medical License
    TX State Medical License 1992 - 1997

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Memory B Cell Marker Predicts Long-Lived Antibody Response to Flu Vaccine
    Memory B Cell Marker Predicts Long-Lived Antibody Response to Flu VaccineMarch 22nd, 2023
  • Indians Remain Wary of Booster Doses as Covid Wanes and Side-Effect Worries Rise
    Indians Remain Wary of Booster Doses as Covid Wanes and Side-Effect Worries RiseJanuary 17th, 2023
  • UAB Vaccine Research Clinic Talks New Booster Shot
    UAB Vaccine Research Clinic Talks New Booster ShotAugust 31st, 2022
  • Join now to see all

Grant Support

  • CTL And HIV Polymorphisms In Heterosexual TransmissionNational Institute Of Allergy And Infectious Diseases2010–2012
  • HIV-1 Cryptic Epitopes: Implications For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
  • ClinicalNational Institute Of Allergy And Infectious Diseases2008–2011
  • HIV-1 Suppression By MHC Class I Restricted CD8 T CellsNational Institute Of Allergy And Infectious Diseases2007–2008
  • Alabama/Zambia HIV Vaccine Clinical Trials Unit (HVTU)National Institute Of Allergy And Infectious Diseases2004–2006
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2002–2005
  • CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2001
  • Human Foamy Virus Structural ProteinsNational Institute Of Allergy And Infectious Diseases1996–2000